The bill amends section 465.1865 of the Florida Statutes to refine the definition of "chronic health condition" within the context of collaborative pharmacy practice. Specifically, it excludes certain heart-related conditions from this definition, namely heart failure, coronary heart disease, and cardiac rhythm disorders. The bill retains the existing list of chronic health conditions, which includes arthritis, asthma, chronic obstructive pulmonary diseases, type 2 diabetes, HIV/AIDS, and obesity, while allowing for the addition of other conditions through rules established by the relevant boards.

The effective date for this legislation is set for July 1, 2025. This change aims to clarify the scope of conditions that pharmacists can collaboratively manage, ensuring that specific heart conditions are not included under the umbrella of chronic health conditions eligible for such practices.

Statutes affected:
H 689 Filed: 465.1865